[186 Pages Report] The Synthetic Biology Market size was estimated at USD 13.88 billion in 2023 and expected to reach USD 16.61 billion in 2024, at a CAGR 21.33% to reach USD 53.76 billion by 2030.
Synthetic biology focuses on applying engineering principles to develop new biological parts, devices, and systems or redesign existing systems found in nature. Synthetic biology incorporates many scientific techniques and approaches to create fully operational biological systems from the smallest constituent parts possible, including DNA, proteins, and other organic molecules. The prevalence of chronic diseases and the need for efficient diagnosis are accelerating the use of synthetic biology for novel drug and vaccine development and innovative point-of-care diagnostics devices. However, hazards and risks associated with synthetic biology technology may limit their use by the end-use industries. Moreover, advancements in gene editing, next-generation sequencing, ongoing research, and significant investments to increase the application of synthetic biology across various end-use sectors are expected to encourage the growth of the synthetic biology market.
Regional Insights
The synthetic biology market is highly evolving across the Americas owing to the growing adoption of synthetic biology in the medical and agricultural sectors, rising investments in genomics and proteomics, and the surging development of improved medical devices using synthetic biology technology. Increasing chronic disease cases and rising emphasis on drug discovery & development are expanding the usage of synthetic biology applications in the APAC region. Moreover, government initiatives and programs to accelerate the use and expand research activities in the synthetic biology field are creating significant potential for the growth of the synthetic biology market in the EMEA region. Additionally, ongoing collaborations and partnership activities, along with the integration of breakthrough technologies for developing cutting-edge devices and technologies to increase their use across various industrial verticals, are expected to encourage the growth of the synthetic biology market worldwide.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Synthetic Biology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Synthetic Biology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Synthetic Biology Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Amyris, Inc., Arzeda, Batavia Biosciences B.V., Beam Therapeutics, Beckman Coulter, Inc., BGI Genomics Co., Ltd., Codexis, Inc., Conagen, Inc., Creative Enzymes, DNA TwoPointO Inc., Editas Medicine, Inc., Eurofins Scientific, GenScript Biotech Corporation, Ginkgo Bioworks, Inc., Illumina, Inc., Integrated DNA Technologies, Inc., Merck KGaA, New England Biolabs GmbH, Novozymes A/S, Precigen, Inc., QIAGEN N.V., Sangamo Therapeutics, Scarab Genomics, LLC, Synlogic, Synthego Corporation, TeselaGen Service, Thermo Fisher Scientific Inc., and Twist Bioscience Corporation.
Market Segmentation & Coverage
This research report categorizes the Synthetic Biology Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Tools
- DNA Tools
- General Tools
- Mathematical Modelling & Computer-aided Design Tools
- Protein Tools
- RNA Tools
- Technology
- Bioinformatics
- Cell Sequencing
- Cell Synthesis & Assembly
- Cloning
- Microfluidics
- Nanotechnology
- Omics Technologies
- Site-directed Mutagenesis
- End-Use
- Agriculture
- Cosmetics & Personal Care
- Energy & Natural Resources
- Environment
- Bioremediation
- Biosensing
- Food & Beverage
- Healthcare & Pharmaceuticals
- Artificial Tissue & Tissue Regeneration
- Drug Discovery & Therapeutics
- Paper & Textile
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
- What is the market size and forecast of the Synthetic Biology Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Synthetic Biology Market?
- What are the technology trends and regulatory frameworks in the Synthetic Biology Market?
- What is the market share of the leading vendors in the Synthetic Biology Market?
- Which modes and strategic moves are suitable for entering the Synthetic Biology Market?
US $
Euro €
GBP £